Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pascal selective laser trabeculoplasty (PSLT) in the treatment of ocular hypertension and open-angle glaucoma compared to travoprost eye drops: A non-inferiority clinical trial.

PloS one·2026
Same author

Preference-based scoring algorithm to estimate societal utilities based on the patient-reported experience of cognitive impairment in schizophrenia (PRECIS) instrument.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Impurity Profiling of an Antibody-Antibiotic Conjugate (AAC) Drug-Linker Using Multiple 2D-LC Modes.

Journal of separation science·2026
Same author

Histological findings after subretinal implantation of the PRIMA photovoltaic array in patients with geographic atrophy due to AMD.

Ophthalmology. Retina·2026
Same author

Residual photoreceptors affect the response of a degenerate retina to electrical stimulation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Understanding Blood-Injection-Injury Phobia: Do Not Miss the Point.

A&A practice·2026

Related Experiment Video

Updated: Mar 21, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.9K

Nondamaging Retinal Laser Therapy: Rationale and Applications to the Macula.

Daniel Lavinsky1, Jenny Wang2, Philip Huie3

  • 1Department of Ophthalmology, Federal University Rio Grande do Sul, Porto Alegre, Brazil.

Investigative Ophthalmology & Visual Science
|May 10, 2016
PubMed
Summary

Nondamaging retinal therapy (NRT) uses a new titration algorithm to safely and effectively treat macular disorders like central serous chorioretinopathy and macular telangiectasia, improving vision and reducing fluid.

More Related Videos

Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish
06:27

Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish

Published on: October 27, 2017

10.5K
A Mouse Model for Laser-induced Choroidal Neovascularization
07:08

A Mouse Model for Laser-induced Choroidal Neovascularization

Published on: December 27, 2015

19.1K

Related Experiment Videos

Last Updated: Mar 21, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.9K
Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish
06:27

Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish

Published on: October 27, 2017

10.5K
A Mouse Model for Laser-induced Choroidal Neovascularization
07:08

A Mouse Model for Laser-induced Choroidal Neovascularization

Published on: December 27, 2015

19.1K

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Laser Therapy

Background:

  • Current retinal photocoagulation and laser therapies lack mechanistic understanding and dosimetry rationale.
  • Macular disorders such as central serous chorioretinopathy (CSCR) and macular telangiectasia (MacTel) require improved treatment strategies.

Purpose of the Study:

  • To establish a titration algorithm for nondamaging retinal therapy (NRT) by measuring tissue response and damage thresholds.
  • To evaluate the safety and efficacy of NRT using this algorithm for chronic CSCR and MacTel.

Main Methods:

  • Assessed retinal response in rabbits via heat shock protein (HSP70) and glial fibrillary acidic protein (GFAP) expression.
  • Utilized the Endpoint Management (EpM) algorithm for energy titration below the damage threshold.
  • Treated 21 eyes with CSCR and 10 with MacTel using high-density NRT at 30% EpM energy, monitoring outcomes for 1 year.

Main Results:

  • HSP70 expression observed at 25% EpM energy, with GFAP upregulation at 1 month; tissue damage initiated at 40% EpM.
  • Complete or partial subretinal fluid resolution in 100% of CSCR patients, with an average visual acuity improvement of 12 letters.
  • MacTel patients showed decreased lacunae, preserved retinal thickness, and an average visual acuity improvement of 10 letters.

Conclusions:

  • Heat shock protein expression defines the therapeutic window for NRT, enabling precise dosimetry.
  • NRT's lack of tissue damage allows for high-density treatment, enhancing efficacy in the fovea and facilitating retreatment for chronic conditions.